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Background: Sporotrichosis is a cutaneous and subcutaneous fungal disease of humans and other mammals,
known to be caused by the Sporothrix schenckii species complex, which comprises four species of clinical
importance: S. brasiliensis, S. globosa, S. luriei, and S. schenckii sensu stricto. Of them, S. globosa and S. schenckii s. str.
show global distribution and differences in global frequency as causal agents of the disease. In the Americas, only
three species are present: S. schenckii s. str., S. brasiliensis (so far, only reported in Brazil), and S. globosa. In Venezuela,
since the first case of sporotrichosis reported in 1935, S. schenckii have been considered its unique etiological agent.
In the present work, the presence of more than one species in the country was evaluated.
Methods: By phenotypic key features and molecular phylogeny analyses, we re-examined 30 isolates from diverse
Venezuelan regions belonging to the fungi collection of Instituto de Biomedicina, Caracas, Venezuela, and national
reference center for skin diseases. All isolates were collected between 1973 and 2013, and maintained in distilled
water.
Results: Sporotrichosis in Venezuela is mainly caused by S. schenckii s. str. (70%). However, a significant proportion
(30%) of sporotrichosis cases in the country can be attributable to S. globosa. A correlation between intraspecific
genotypes and clinical presentation is proposed.
Conclusions: Our data suggest that sporotrichosis various clinical forms might be related to genetic diversity of
isolates, and possibly, to diverse virulence profiles previously reported in the S. schenckii species complex. Sporothrix
globosa was found to be the causative agent of 30% of sporotrichosis for the Venezuelan cases re-examined, the
highest frequency of this species so far reported in the Americas. The high genetic variability presented by S.
schenckii s. str. indicates that species distinction based on phenotypic key features could be a challenging and
uncertain task; molecular identification should be always employed.
Keywords: Sporothrix schenckii species complex, Sporothrix globosa, Sporotrichosis, Clinical forms, Phenotypic
identification, Phylogenetic analysis, American continent, VenezuelaBackground
Over the last few years, the Sporothrix schenckii species
complex (formerly known as S. schenckii) has received
special interest due to the increasing number of infec-
tions caused by it worldwide, particularly in immuno-
compromised patients [1], and epidemic outbreaks in
cats in Brazil [2]. It is responsible for sporotrichosis, a* Correspondence: gnino@ivic.gob.ve
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unless otherwise stated.chronic granulomatous subcutaneous mycosis of humans
and other mammals. Primary infection has been reported
as caused by traumatic inoculation of environmental ma-
terial carrying saprophytic hyphae and conidia of the etio-
logic agents [2,3]. Once into the warm-blooded host, these
dimorphic fungi are capable to convert into pathogenic
yeasts, causing infections that range from fixed cutaneous
localized lesions to severe disseminated sporotrichosis
[3-5]. However, zoonotic transmission is also possible, by
scratches or bites from asymptomatic or infected animals,
with cats being the main vectors through which theral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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The last makes direct inoculation of pathogenic yeast a
plausible source of infection. Although the disease has a
global occurrence, endemic areas are mostly located in
tropical and subtropical countries [6,9]; furthermore, Spor-
othrix infections may take epidemic proportions [7,8,10]
and its distinct etiological agents differ in virulence pro-
files [11-13], antifungal susceptibility [14,15], and geo-
graphic distribution [16].
Molecular phylogenetic analyses have led to descrip-
tion of at least four cryptic species of clinical relevance
within the S. schenckii species complex, comprising S.
brasiliensis, S. schenckii sensu stricto (s. str), S. globosa
and S. luriei [2,8,17-19]. Scattered reports of Sporothrix
spp. outside these four clades, causing clinical cases have
been published, such as S. mexicana [16,20] and S. pal-
lida [21], or by close relatives in the genus Ophiostoma,
i.e. O. piceae [22] and O. stenoceras [23]. However, these
species appear to lack human-pathogenic potential, thus
they are proposed to be accidentally pathogenic [17].
Besides molecular phylogeny, morphological and physio-
logical key features have been proposed for species recog-
nition within the Sporothrix species complex [18,19].
In Venezuela, sporotrichosis is the second most com-
mon subcutaneous mycosis after chromomycosis. It was
first described in 1935, nevertheless the exact prevalence
in the country is unknown [24]. According to conven-
tional mycological procedures, as well as epidemiological
data, all isolates related to sporotrichosis have been
identified as Sporothrix schenckii.
The aim of the present study was to determine if, be-
sides S. schenckii, other Sporothrix species of the com-
plex might be present in the country. We re-examined
30 isolates, by phenotypic and molecular methods, dis-
covering that S. globosa was the etiological agent in one
third of the cases.
Methods
Fungal isolates and strains used
Thirty isolates (29 clinical and 1 environmental) from
different Venezuelan regions (Coastal range; n = 22, The
Andes; n = 7; The Plains; n = 2) were examined in this
study (Table 1). All isolates were previously identified as
S. schenckii by means of morphology (macro and micro-
scopic studies), ability of isolates to reverse to yeast-like
cells at 37°C, and serological tests to patients from where
they were isolated, all performed in the Mycology Labora-
tory at Instituto de Biomedicina, Caracas, Venezuela, a na-
tional reference center for skin diseases. Isolates were
taken as part of standard patient care, and no ethical ap-
proval was required for their use. They have been kept as
part of the laboratory fungal collection over a period of
40 years (from 1973 to 2013) and were selected for inclu-
sion in this study based on their geographic distribution.They were preserved in distilled water (Castellani’s
method), and recovered by growth on Sabouraud dex-
trose agar (SDA) complemented with 150 μg ml−1chlor-
amphenicol at room temperature during 7 days. As
reference, strains S. schenckii s. str. ATCC-MYA 4820,
and S. brasiliensis ATCC-MYA 4823 (provided by Dr. L.
Bezerra, Universidade do Estado do Rio de Janeiro, Brazil),
as well as S. pallida CBS 302.73T, S. globosa FMR 9023,
and S. mexicana FMR 9108 kindly provided by Dr. J. Cano
(Reus, Spain) were used.
Phenotypic characterization
Isolates were phenotypically identified according to
Marimon et al. [18]. Macroscopic features of colonies
were studied by culturing isolates on potato dextrose
agar (PDA, HIMEDIA, India) plates, incubated at room
temperature (growth control), 30°C and 37°C in dark.
Petri dishes (90 × 15 mm, with 8 mm PDA) were cen-
trally inoculated with portions of the colonies of the
fungi, approximately 1 mm in diameter, and incubated
upside down. After 14 and 21 days, colony diameters
(in millimeters) were measured in duplicate for growth
temperatures of 30°C and 37°C, and the mean of the re-
corded measured diameters taken for final analysis.
Microscopic features of conidia were found to be the
same for reference strains and a sample of Venezuelan
isolates when lactrimel agar (LA) was used instead of
the corn meal agar (CMA) used by Marimon et al. [18].
So for the rest of the study, microscopic features of co-
nidia were determined from slide cultures made on lac-
trimel agar (10 g honey, 20 g wheat flour, 200 ml milk,
9.5 g agar, 800 ml distilled water and 150 μg ml−1 chlor-
amphenicol) after 12–15 days of incubation in the dark
in a humid chamber. Coverslips were mounted in lacto-
phenol cotton blue (0.05% (w/v)), 2% phenol, 2% lactic
acid and 4% glycerin), and examined under a light micro-
scope (Leica DM2000) at 40X and 100X. Carbohydrate as-
similation tests for sucrose and raffinose were conducted
in 96-well microplates, using 150-μl of a working solution
composed of yeast nitrogen base (YNB) medium (Sigma-
Aldrich, USA) with corresponding test sugar, or plain
(only base medium), as described by Marimon et al. [18].
Briefly, the isolates were grown on potato dextrose broth
for 7 days at 23°C, or on Brain-Heart Infusion agar (BHI,
OXOID, England), at 30°C for isolates that did not sporu-
lated with the previous conditions. Conidia were collected
by filtering 10 to 20 ml liquid culture through sterile gauze
and quantified in a spectrophotometer at 600 nm. Each
suspension was adjusted to an optical density that ranged
from 0.21 to 0.29, corresponding to a final inoculum in
the microplate of 2×105 to 2×106 CFU/ml. Each well was
inoculated with 50 μl inoculum and 150 μl YNB medium
with corresponding carbohydrate, at a final concentra-
tion of 3.75%. YNB medium without sugar was used as




Source Origin GenBank Accession N°
CAL ITS
C0014 S. schenckii Clinical, Human (lymphocutaneous) Coastal range (Distrito Capital, Venezuela) 1KF478909 1KJ999877
C0329 S. globosa Clinical, Human (fixed cutaneous) The Andes (Táchira, Venezuela) 1KF478892 1KJ999878
C0596 S. schenckii Clinical, Human (fixed cutaneous) Coastal range (Miranda, Venezuela 1KF478896 1KJ999879
C1163 S. schenckii Clinical, Human (lymphocutaneous) Coastal range (Distrito Capital, Venezuela) 1KF478910 1KJ999880
C2606 S. schenckii NA Coastal range (Distrito Capital, Venezuela) 1KF478887 1KJ999881
C2656 S. schenckii Clinical, Human (fixed cutaneous) The Andes (Trujillo, Venezuela) 1KF478897 1KJ999882
C2745 S. schenckii Clinical, Human (fixed cutaneous) The Plains (Monagas, Venezuela) 1KF478891 1KJ999883
C2888 S. schenckii Clinical, Human (lymphocutaneous) Coastal range (Distrito Capital, Venezuela) 1KF478886 1KJ999884
C3037 S. schenckii Clinical, Human (disseminated) Coastal range (Distrito Capital, Venezuela) 1KF478888 1KJ999885
C3527 S. schenckii NA Coastal range (Distrito Capital, Venezuela) 1KF478898 1KJ999886
C3673 S. globosa Clinical, Human (fixed cutaneous) Coastal range (Distrito Capital, Venezuela) 1KF478892 1KJ999887
C3705 S. schenckii Clinical, Human (lymphocutaneous) Coastal range (Distrito Capital, Venezuela) 1KF478884 1KJ999888
C4346 S. schenckii Clinical, Human (lymphocutaneous) Coastal range (Distrito Capital, Venezuela) 1KF478889 1KJ999889
C5000 S. schenckii Clinical, Human (lymphocutaneous) Coastal range (Aragua, Venezuela) 1KF478885 1KJ999890
C5859 S. globosa Clinical, Human (fixed cutaneous) Coastal range (Vargas, Venezuela) 1KF478893 1KJ999891
C7012 S. schenckii Clinical, Human (lymphocutaneous) The Andes (Táchira, Venezuela) 1KF478899 1KJ999892
C8213 O. stenoceras Clinical, Human (fixed cutaneous) Coastal range (Distrito Capital, Venezuela) 1KF478913 1KJ999893
C8287 S. schenckii Clinical, Human (fixed cutaneous) Coastal range (Distrito Capital, Venezuela) 1KF478900 1KJ999894
C8704 S. schenckii NA Coastal range (Distrito Capital, Venezuela) 1KF478890 1KJ999895
C8775 S. globosa Clinical, Human (fixed cutaneous) Coastal range (Aragua, Venezuela) 1KF478901 1KJ999896
C8857 S. globosa Clinical, Human (fixed cutaneous) The Andes (Trujillo, Venezuela) 1KF478902 1KJ999897
C8888 S. schenckii Clinical, Human (lymphocutaneous) The Andes (Trujillo, Venezuela) 1KF478903 1KJ999898
C8962 S. globosa Clinical, Human (fixed cutaneous) The Plains (Cojedes, Venezuela) 1KF478904 1KJ999899
C8981 S. globosa Clinical, Human (fixed cutaneous) The Andes (Mérida, Venezuela) 1KF478905 1KJ999900
C9254 S. globosa Clinical, Human (fixed cutaneous) Coastal range (Distrito Capital, Venezuela) 1KF478911 1KJ999901
C9300 S. schenckii Clinical, Human (lymphocutaneous) The Andes (Trujillo, Venezuela) 1KF478906 1KJ999902
C9526 S. schenckii NA Coastal range (Distrito Capital, Venezuela) 1KF478907 1KJ999903
C9862 S. schenckii Clinical, Human (fixed cutaneous) Coastal range (Distrito Capital, Venezuela) 1KF478912 1KJ999904
C9887 S. globosa Clinical, Human (fixed cutaneous) Coastal range (Distrito Capital, Venezuela) 1KF478908 1KJ999905
A0001 S. schenckii Environmental, Soil Coastal range (Aragua, Venezuela) 1KF478894 1KJ999876
ATCC MYA-4820 S. schenckii Clinical, Human Brazil 2JF313361 3JQ070111
ATCC MYA-4823 S. brasiliensis Feline sporothricosis Brazil 2JF313351 3JQ070114
CBS 302.73T S. pallida Environmental United Kingdom 4AM398396 1KJ999906
FMR 9023 S. globosa Clinical, Human Japan 4AM398393 1KJ999907
FMR 9108 S. mexicana Environmental Mexico 4AM398393 5FN549906
Previously genotyped strains used as reference, in bold.
1This study; 2Teixeira, M. and Lopes-Bezerra, L.M., direct submission; 3Suh, S.-O. and Zhou, J.J, direct submission; 4ATCC Mycology Authentication Project.
5Madrid et al. [33]. NA, data non-available.
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croplates were read at 5 and 10 days of incubation at
25°C, experiments were conducted by duplicate. The via-
bility of the conidia was verified by plating 20 μl of a 1:500
dilution of each inoculum onto YPD (0.5% yeast, 0.5%
peptone, 1.5% dextrose) plates. In case of discordantresults, experiments were repeated at least two additional
times on different days.
Molecular characterization
Total genomic DNA was isolated from 3-day-old myce-
lial cultures grown on YPD broth, following the protocol
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(CAL) locus was obtained by using degenerated primers
CL1 and CL2A [26], amplifying a region corresponding
to exons 3 through 5 of the CAL gene. ITS regions were
amplified from genomic DNA with universal primers
ITS5 and ITS4 as described by Zhou et al. [17]. Follow-
ing PCR, amplicons were purified with the CONCERT™
Rapid PCR purification system (Life Technologies, USA)
and sent for sequencing on both strands to Macrogen
Inc (Seoul, Korea), with the same primers used for PCR.
Assembly of the sequences was done with the Contig
program within the Vector NTI suite (Vector NTI,
InforMax, Inc, USA). Homology searches were per-
formed on GenBank database using BLAST [27]. The
newly reported sequences generated in this study were
deposited in the GenBank/EMBL/DDBJ database under
accession numbers listed in Table 1.
Phylogenetic analysis
Sporothrix-calmudulin-related and Sporothrix-ITS-related
sequences, previously reported to be obtained with the
same two sets of primers here used, were retrieved from
Genbank and included in the analyses (Figures 1 and 2)
[16,18]. As an outgroup, the saprophytic fungus Grosman-
nia serpens (Ophiostomataceae) [28] was included for
the CAL analysis. The multiple nucleotide sequence
alignment was performed using the ClustalW algorithm
implemented in MEGA5.2 software [29]. Evolutionary
analyses were also conducted in MEGA5.2 as described
by Rodrigues et al. [16].
Genetic variation analysis
To evaluate genetic variation, the CAL locus was used
as nuclear marker. Nucleotide (π) and haplotype (Hd)
diversities [30] were estimated using DnaSP software,
version 5.10.01 [31]. Sites containing gaps and missing
data were not considered in the analysis.
Results
A total of 30 previously identified S. schenckii Venezuelan
isolates (29 clinical and 1 environmental) (Table 1) were
re-examined on the basis of phenotypic key features (i.e.
growth at various temperatures, macroscopic and micro-
scopic features, and carbohydrate assimilation, according
to Marimon et al. [18]), as well as molecular phylogeny
inferred from CAL and ITS sequences. Based on the result
obtained for reference strain S. globosa FMR 9023
(Table 2), restricted growth at 37°C was set at ≤ 6.4 mm
colony diameter (maximum diameter reached in our study
by this reference strain, previously identified by Marimon
et al. [18]). Only 8 out of 30 isolates (26.67%) were clearly
identified when the summary of key features for Sporo-
thrix species differentiation, proposed by Marimon et al.
[18], was strictly followed (Table 2).One isolate, S. schenckii C8287, was misidentified by
following the phenotypic features solely, requiring mo-
lecular genotyping for proper identification; it was
labeled as S. globosa due to its restrictive growth at
37°C, and positive/negative assimilation profile for su-
crose and raffinose. The remaining 21 isolates (70.00%)
showed inconclusive results, requiring molecular geno-
typing for proper identification (Table 2). The most
ambiguous results (colony growth over 50 mm diam-
eter at 30°C and/or negative assimilation of raffinose)
were shown by S. schenckii s. str. isolates, for which
just 2 out of 20 (10%) were properly identified without
the need of molecular phylogeny analysis. However, it
is important to notice that when the microscopic fea-
tures of sessile conidia (pigmentation and morphology)
were taken solely, correlation between identification by
these features and molecular identification was found
(Table 2).
Genotyping of the isolates was performed by using the
amplified fragment from the CAL locus. The complete
alignment included 90 sequences, 30 generated in this
study and 60 retrieved from previous studies, respect-
ively [16,18]. The aligned CAL sequences were 595 bp
long, including 302 invariable characters, 239 variable
parsimony-informative sites (40.17%) and 43 singletons.
Twenty nine (29) of the 30 Venezuelan isolates clustered
within the clinical clades (as defined by previous phylo-
genetic analyses of Sporothrix spp. based on CAL
[6,16,32]). Of those 29 isolates, 20 (>60%) grouped as S.
schenckii s. str., while 9 (30%) grouped as S. globosa
(Figure 1). One isolate (C8213), clustered within the
environmental clades as O. stenoceras (Figure 1). To
corroborate these results, a second phylogenetic ana-
lysis was performed, using ITS sequences generated by
the universal primers ITS4 and ITS5. Seventy four (74)
nucleotide sequences, 30 generated in this study and 44
previously reported [17] were aligned. The aligned ITS
sequences were 506 bp long, including 407 invariable
characters, 85 variable parsimony-informative sites (16.79%)
and 12 singletons. The Venezuelan isolates were distrib-
uted in complete agreement with the CAL-generated
phylogeny, with the Venezuelan isolates of S. schenckii s.
str. and S. globosa (pathogenic species), and O. stenoceras
(accidentally pathogenic species) showing strong, statisti-
cally supported separation (99% bootstrap) between clin-
ical and environmental clades (Figure 2).
Assessment of the Venezuelan Sporothrix population
genetic diversity was explored by using the DnaSP soft-
ware [31] and CAL as nuclear marker. The haplotype
analysis of calmodulin sequences (n = 65) divided the
isolates into 17 Hap groups. A total of 15 and 5 different
types were detected for S. schenckii s. str. and S. globosa,
respectively. The majority of haplotypes (Hd = 0.85)
belonged to S. schenckii s. str., demonstrating a highly
Figure 1 (See legend on next page.)
Camacho et al. BMC Infectious Diseases  (2015) 15:94 Page 5 of 10
(See figure on previous page.)
Figure 1 Phylogenetic relationships of Sporothrix schenckii complex isolates, inferred from CAL sequences. The phylogenetic tree was
built with MEGA 5.1, by the Maximum Likelihood method based on the Kimura 2-parameter model. Thirty sequences from this study and sixty
retrieved from previous studies were used for analysis. Number close to branches represents Bootstraps support values based on 1000 bootstrap
replications. GenBank accessions numbers are indicated next to strain code in branch labels.
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sented low genetic variation (Hd = 0.59; π = 0.005).
According to epidemiological data of clinical cases for
the Venezuelan isolates, most of them were geographic-
ally restricted to the coastal range region (68.97%). An
analysis of the distribution by gender showed a higher
occurrence in male patients (64%) compared to women
(36%). The most predominant clinical form in this study
was fixed cutaneous (60%), followed by lymphocuta-
neous (36%) and one case of disseminated sporotrichosis
(4%).
An association between clinical forms and phylogen-
etic species was found (Figure 3). All lymphocutaneous
cases (100%) were caused by S. schenckii s. str., while
fixed cutaneous cases were attributable to both, S.
schenckii s. str. (33.3%) and S. globosa (60.0%), plus a sin-
gle case by O. stenoceras. The only case with dissemi-
nated manifestations was related to S. schenckii s. str.
Discussion
Even though sporotrichosis is a cosmopolitan subcutane-
ous mycosis, the species grouped in the clinical clades
have shown a geographical distribution [17]. S. schenckii
s. str. presents a frequency over 50% in America, while S.
globosa has prevailed in Asia and Europe (56% and 28%,
respectively), followed by the Americas (11%) [17]. In
the present study, thirty fungal isolates related to sporo-
trichosis in Venezuela, and previously identified by mor-
phological studies as S. schenckii, were characterized by
phenotypic key features and molecular phylogeny. The
results show that in the country, at least two species are
circulating: S. schenckii s. str. and S. globosa. Although S.
schenckii s. str. is the main circulating species, with over
60% of evaluated cases, S. globosa could be considered
the second most frequent species causing sporotrichosis
in Venezuela. The incidence of S. globosa, with 30% of
cases evaluated, is the highest reported so far in the
Americas for this species, and is similar to its reported
incidence in Europe [17]. An interesting finding is the
fact that all S. globosa isolates here characterized, were
related to fixed cutaneous sporotrichosis, which could
be related to the low virulence reported for this species
[33,34]. On the other hand, 100% of the lymphocuta-
neous cases, and the single disseminated case were all
related to S. schenckii s. str., as well as 33% of fixed cuta-
neous sporotrichosis.
In a recent study [13], the virulence profiles of eight S.
schenckii s. str. were evaluated, and different degrees ofvirulence were found for this species, from high viru-
lence to non-virulence. High genetic variation have been
reported for S. schenckii s. str. [15,33,35]. Here, we also
found high genetic variation for the Venezuelan S.
schenckii s. str. isolates evaluated (Hd = 0.85; π = 0.020),
while low genetic variation was obtained for the S. glo-
bosa isolates (Hd = 0.59; π = 0.005). Summing up the
preceding results, we could hypothesize that a relationship
might be present between the high genetic variation, dif-
ferent clinical presentations, and multiple virulence levels
found for S. schenckii s. str., while the low genetic variation
of S. globosa isolates might be related to a single clinical
presentation (fixed cutaneous sporotrichosis), and low
virulence profiles related to this species [11,13]. However,
in Northeast China, clinical cases of sporotrichosis (from
fixed cutaneous to disseminated forms), have been attrib-
utable exclusively to S. globosa [36]. To confirm or discard
our hypothesis, further studies are required, evaluating
whether correlations can be found between virulence pro-
files, species, patient’s immunological conditions, and clin-
ical presentation of isolate’s source.
Earlier characterization reports of Sporothrix spp. com-
paring the phenotypic key features for species identifica-
tion proposed by Marimon et al. [18], and molecular
phylogeny methodologies, have shown few disagreements
for species identification [13,16,32,37]. In the present
study, a high proportion (70%) of Venezuelan isolates re-
lated to sporotrichosis, were not identified according to
their phenotype key features (as proposed by Marimon
et al. [18]). We discarded a technical problem, since all
reference strains were accurately identified by this method
(Table 2). So, at least for the Venezuelan isolates here
studied, the phenotypic characterization was not useful
for species identification.
In our molecular phylogenetic analyses based on CAL
and ITS sequences, a strong separation between clinical
and environmental clades was evident (Figures 1 and 2),
in correspondence with previous reports [6,16-18,33].
Isolate C8213, identified as O. stenoceras was isolated
from an immunocompetent patient, supporting the idea
that mammal-pathogenicity of Ophiostomales, outside
the S. schenckii spp. complex, although highly excep-
tional [17], still can occur. To the best of our knowledge,
this is the first report of O. stenoceras misidentified as
causative agent of sporotrichosis in the Americas. Fur-
ther studies into the mechanisms of opportunistic fungal
pathogenesis would help to understand why a harmless
fungus, as O. stenoceras, could become an infective
Figure 2 (See legend on next page.)
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Figure 2 Phylogenetic relationships of Sporothrix schenckii complex isolates inferred from ITS sequences. The phylogenetic tree was built
with MEGA 5.1, by the Maximum Likelihood method based on the Kimura 2-parameter model. Thirty sequences from this study and forty four
from previous reports were used for analysis. Number close to branches represents Bootstraps support values based on 1000 bootstrap replications.
GenBank accessions numbers are indicated next to strain code.
Table 2 Isolates characterized by phenotypic and molecular methods included in the study
Isolate Mean colony diameter (mm) ± SD
on PDA during 21 days







ITS sequences30°C 37°C Sucrose Raffinose
C0014 45.5 ± 0.7 12.0 ± 0.0 + - Triangular NC S. schenckii
C0329 46.5 ± 2.1 6.5 ± 0.7 + - Subglobose NC S. globosa
C0596 53.5 ± 0.7 23.0 ± 0.0 + - Triangular NC S. schenckii
C1163 52.5 ± 2.1 11.5 ± 0.7 + + Triangular NC S. schenckii
C2606 56.0 ± 0.0 11.5 ± 0.7 + - Triangular NC S. schenckii
C2656 52.5 ± 0.7 13.5 ± 0.7 + - Triangular NC S. schenckii
C2745 45.5 ± 0.7 10.0 ± 0.0 + - Triangular NC S. schenckii
C2888 53.5 ± 0.7 12.5 ± 0.7 + - Triangular NC S. schenckii
C3037 57.0 ± 1.4 15.0 ± 0.0 + + Triangular NC S. schenckii
C3527 54.0 ± 1.4 17.0 ± 1.4 + + Triangular NC S. schenckii
C3673 41.5 ± 0.7 5.5 ± 0.7 + - Globose S. globosa S. globosa
C3705 50.0 ± 1.4 17.0 ± 1.4 + + Triangular S. schenckii S. schenckii
C4346 52.0 ± 1.4 15.0 ± 0.0 + + Triangular NC S. schenckii
C5000 55.5 ± 0.7 16.5 ± 0.7 + + Triangular NC S. schenckii
C5859 38.0 ± 0.0 4.0 ± 0.0 + - Globose S. globosa S. globosa
C7012 58.0 ± 0.0 22.0 ± 0.0 + + Triangular NC S. schenckii
†C8213 25.5 ± 4.9 12.7 ± 3.1 + - NP NC O. stenoceras
†C8287 30.0 ± 0.0 3.0 ± 0.0 + - Triangular S. globosa S. schenckii
C8704 44.5 ± 0.7 7.0 ± 1.4 + - Triangular NC S. schenckii
†C8775 23.0 ± 0.0 3.0 ± 2.8 - - Subglobose NC S. globosa
C8857 33.5 ± 0.7 3.0 ± 2.8 + - Subglobose S. globosa S. globosa
C8888 52.5 ± 0.7 14.5 ± 0.7 + - Triangular NC S. schenckii
C8962 41.0 ± 0.0 5.5 ± 0.7 + - Subglobose S. globosa S. globosa
C8981 38.0 ± 0.0 3.0 ± 0.0 + - Globose S. globosa S. globosa
C9254 44.5 ± 0.7 8.0 ± 0.0 + - Globose NC S. globosa
C9300 44.5 ± 0.7 13.5 ± 0.7 + - Triangular NC S. schenckii
C9526 42.0 ± 0.0 13.5 ± 0.7 + + Triangular S. schenckii S. schenckii
C9862 52.5 ± 2.1 12.0 ± 1.4 + - Triangular NC S. schenckii
C9887 37.5 ± 0.7 3.5 ± 0.7 + - Globose S. globosa S. globosa
A0001 58.5 ± 0.7 15.5 ± 0.7 + - Triangular NC S. schenckii
ATCC MYA-4820 41.0 ± 0.0 13.0 ± 1.4 + + Triangular S. schenckii S. schenckii
ATCC MYA-4823 43.5 ± 0.7 13.0 ± 1.4 - - Globose S. brasiliensis S. brasiliensis
CBS 302.73T 76.5 ± 0.7 11.0 ± 0.0 + - NP S. pallida S. pallida
FMR 9023 33.5 ± 0.7 5.0 ± 1.4 + - Subglobose S. globosa S. globosa
FMR 9108 73.0 ± 1.4 16.5 ± 0.7 + + Ellipsoidal S. mexicana S. mexicana
Reference strains in bold.
NC, non-conclusive; NP, not present; †Isolates showing atypical phenotypic profiles.
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Figure 3 Frequency of clinical forms of sporotrichosis vs. phylogenetic species. DS, disseminated; LC, lymphocutaneous; FC, fixed cutaneous.
Information corresponds to clinical cases with available epidemiological data (Table 1).
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comes even more relevant, when we consider the in-
creasing number of reports of Sporothrix infection in
immunocompromised patients, mainly the HIV-infected
population [1].
Even when selection of the isolates here studied was
made trying to cover a broad geographical area of the
country, most isolates originated from clinical cases of
the coastal region, which can be explained, besides it be-
ing a possible ecological niche for the species, to the fact
that although this area covers only 3% of the total sur-
face of the country, it is also the most heavily populated
region. Further work with larger data on molecular epi-
demiology of sporotrichosis in Venezuela is required to
verify whether correlation between clinical forms and
phylogenetic species exists, and gain better knowledge
about S. schenckii species complex spatial distribution in
the country.
Conclusions
The present study shows that sporotrichosis in
Venezuela is caused at least by two species: S.
schenckii s. str. and S. globosa, the latter representing
the highest incidence reported in the Americas (30%).
Our results firmly demonstrate that phenotypic key
features for species distinction should be used withextreme caution and molecular methods should be always
employed. Sporotrichosis clinical forms could be related
to genetic variation of S. schenckii spp. complex and their
virulence profiles. We strongly support application of ITS
as a fungal barcoding gene for species distinction of all
clinical and environmental clades of Sporothrix, and acci-
dental infective agents within the Ophiostomales.
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